Gilead Sciences
GILD
#129
Rank
C$208.76 B
Marketcap
C$168.25
Share price
0.36%
Change (1 day)
31.62%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): C$13.85 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are C$29.08 Billion. In 2024 the company made an earning of C$0.95 Billion a decrease over its 2023 earnings that were of C$9.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$13.85 B1345.44%
2024 C$0.95 B-89.94%
2023 C$9.52 B17.97%
2022 C$8.07 B-29.77%
2021 C$11.50 B395.99%
2020 C$2.31 B-67.66%
2019 C$7.16 B-33.84%
2018 C$10.83 B-42.35%
2017 C$18.79 B-20.87%
2016 C$23.75 B-21.06%
2015 C$30.09 B45.8%
2014 C$20.63 B253.01%
2013 C$5.84 B16.51%
2012 C$5.01 B-1.07%
2011 C$5.07 B-6.71%
2010 C$5.43 B11.75%
2009 C$4.86 B29.5%
2008 C$3.75 B19.11%
2007 C$3.15 B-455.74%
2006 -C$0.89 Billion-154.93%
2005 C$1.61 B76.99%
2004 C$0.91 B-266.16%
2003 -C$0.55 Billion-638.24%
2002 C$0.10 B31.5%
2001 C$77.55 M-242.15%
2000 -C$54.56 Million-40.2%
1999 -C$91.23 Million31.85%
1998 -C$69.2 Million8.73%
1997 -C$63.64 Million27.22%
1996 -C$50.02 Million
1994 -C$47.66 Million26.57%
1993 -C$37.66 Million46.49%
1992 -C$25.71 Million362.5%
1991 -C$5.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.45 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.19 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.30 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.38 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.64 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.46 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$45.01 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.26 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$32.08 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA